Ask Warren

Aribiolab

261780 · KOSDAQ · ₩261780 · 아리바이오랩

₩3,400▼ ₩185 (5.16%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)

    Predicted impact: Medium· Actual: −9.0% vs sector, volume 0.4× normal (5 trading days)

    Voluntary report of securities issuance results; size unknown, but the company is tiny with revenue near zero.

    Oct 16, 2026Open on DART
  • Material Matters Report (Sale of Own Convertible Bonds Decision)주요사항보고서(자기전환사채매도결정)

    Predicted impact: Medium

    Company decision to sell its own convertible bonds; size unknown, market value is large versus tiny revenue.

    Oct 16, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항 (경영지배인 사임)Oct 6, 2026Open on DART
  • Decision to Acquire Equity-Linked Bonds주권관련사채권의취득결정Sep 29, 2026Open on DART
  • Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)Sep 28, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Sep 22, 2026Open on DART
  • Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)Sep 22, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Sep 16, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 16, 2026Open on DART
  • Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Sep 16, 2026Open on DART
  • Convertible bond issue decision주요사항보고서(전환사채권발행결정)Sep 14, 2026Open on DART
  • Amended: Change of largest shareholder[기재정정]최대주주변경을수반하는주식담보제공계약체결Sep 9, 2026Open on DART
  • Convertible bond issue decision주요사항보고서(전환사채권발행결정)Sep 9, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 7, 2026Open on DART
  • Results of Extraordinary Shareholders' Meeting임시주주총회결과Aug 5, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jul 31, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Jul 31, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Jul 31, 2026Open on DART
  • Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Jul 23, 2026Open on DART
  • Amended: Shareholders' meeting called[기재정정]주주총회소집결의Jul 15, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Jul 15, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Jul 15, 2026Open on DART
  • Adjustment of Conversion Price전환가액의조정Jun 30, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jun 30, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Jun 30, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Jun 30, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Jun 22, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의 (임시주주총회)Jun 22, 2026Open on DART
  • Amended attachment: Convertible bond issue decision[첨부정정]주요사항보고서(전환사채권발행결정)Jun 22, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jun 22, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 10, 2026Open on DART
  • Change of largest shareholder최대주주변경을수반하는주식담보제공계약체결Jun 9, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jun 5, 2026Open on DART
  • Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)Jun 5, 2026Open on DART
  • Change of largest shareholder최대주주변경을수반하는주식담보제공계약해제ㆍ취소등Jun 1, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)May 29, 2026Open on DART
  • Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)May 28, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항 (경영지배인 선임의 건)May 15, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • Convertible bond issue decision주요사항보고서(전환사채권발행결정)May 15, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)May 11, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)May 11, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)May 8, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 8, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)May 8, 2026Open on DART
  • Decision to Acquire Equity-Linked Bonds주권관련사채권의취득결정May 4, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고May 4, 2026Open on DART
  • Change of largest shareholder최대주주변경을수반하는주식담보제공계약체결Apr 30, 2026Open on DART
  • Change of CEO대표이사변경Apr 30, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: Aribiolab / 아리바이오랩 / 261780 / KRX:261780

Source: KRX statistical information